Quazepam

Drug Profile

Quazepam

Alternative Names: Doral; SCH 161; SCH 16134

Latest Information Update: 27 Aug 2014

Price : $50

At a glance

  • Originator Schering-Plough
  • Class Benzodiazepines; Hypnosedatives; Sleep disorder therapies; Small molecules
  • Mechanism of Action GABA A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Sleep disorders

Most Recent Events

  • 14 Aug 2014 Questcor Pharmaceuticals has been acquired by Mallinckrodt plc
  • 01 Oct 2007 Mitsubishi Pharma Corporation has merged with Tanabe Seiyaku to form Mitsubishi Tanabe Pharma Corporation
  • 05 May 2006 Quazepam has been licensed to Questcor Pharmaceuticals in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top